TrialGastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association2025

Neoadjuvant docetaxel, oxaliplatin, and S-1 therapy for patients with large type 3 or type 4 gastric cancer: short-term outcomes of a multicenter, phase II study (OGSG1902).

Ryo Tanaka et al.PubMed ↗Publisher ↗

No numbers read from the abstract.